Search

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...

World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness

Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.

‘Let’s place focus on Scotland’s vast innovation opportunities during National Eye Health Week’

National Eye Health Week (NEHW) could provide essential inspiration for NHS Scotland staff looking to focus on fresh ophthalmic innovation, says InnoScot Health. This year's NEHW is taking place from 23 to 29 September under an inclusive theme of ‘Vision...

Dry eye disease treatments come to the fore at 100%

Guidance on setting up, or enhancing, a Dry Eye disease clinic within the practice will be freely available from OSA members exhibiting at 100% Optical: 1–3 March. The ability to diagnose and treat a major irritation for many is winning...

Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people

The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...

Study flags evidence gaps in AI eye imaging devices approved for patient care

Uneven evidence and poor data transparency revealed in review of AI as a medical device. A review of regulator-approved medical AI models in eye care has found that they vary widely in providing evidence for clinical performance and lacked transparency...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

The College of Optometrists announces new research scholarships, grants and bursaries are open for applications

The College of Optometrists has announced its programme of financial support for undergraduate students, postgraduate students and members engaging in research projects in the 2025-2026 academic year is open for applications. The College has a long history of providing financial...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...